Hanmi Science Aktie
WKN: 955964 / ISIN: KR7008930000
23.07.2025 15:11:12
|
Hanmi (HAFC) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.Need a quote from one of our analysts? Email pr@fool.comHanmi Financial (NASDAQ:HAFC) reported sequential growth in net interest income and margin, with disciplined expense management maintaining the efficiency ratio at 55.7% despite elevated credit loss expenses. Asset quality metrics improved markedly, including substantial reductions in criticized and non-accrual loans, supported by strategic portfolio actions and successful upgrades. Deposit and loan growth continued, with management increasing targets for SBA production and highlighting expanded C&I banker teams supporting future pipeline strength. Strategic emphasis remains on C&I, SBA, and relationship-driven deposit growth, while exposure to CRE is being reduced as a percentage of the loan mix.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Q2 Holdings Incmehr Nachrichten
06.05.25 |
Ausblick: Q2 legt die Bilanz zum abgelaufenen Quartal vor (finanzen.net) | |
11.02.25 |
Ausblick: Q2 stellt Ergebnisse des abgelaufenen Quartals vor (finanzen.net) |
Analysen zu Q2 Holdings Incmehr Analysen
Aktien in diesem Artikel
Hanmi Science Co Ltd. | 50 000,00 | 2,99% |
|
Q2 Holdings Inc | 76,50 | -0,65% |
|